Oxford BioDynamics Plc (LON:OBD – Get Free Report) crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of GBX 0.11 and traded as low as GBX 0.10. Oxford BioDynamics shares last traded at GBX 0.10, with a volume of 78,381,070 shares traded.
Oxford BioDynamics Stock Performance
The company has a quick ratio of 2.80, a current ratio of 2.01 and a debt-to-equity ratio of 131.61. The company’s 50-day moving average is GBX 0.11 and its two-hundred day moving average is GBX 0.16. The company has a market capitalization of £13.44 million, a P/E ratio of -0.50 and a beta of 0.42.
About Oxford BioDynamics
Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases. Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022. In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Recommended Stories
- Five stocks we like better than Oxford BioDynamics
- Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?
- Keysight Technologies: The Tollbooth on the Technology Superhighway
- Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
- Bargain Hunting: Why Off-Price Retail Is Winning
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
